Automata Technologies Secures $40M Funding for Lab Automation
Automata Technologies, a London-based automation company for life sciences labs, has recently secured $40M in funding. The funding round was led by Dimension and saw participation from A.P. Moller Holding, Octopus Ventures, Hummingbird, Isomer Capital, Possible Ventures, and Aldea Ventures who were returning investors. With this influx of capital, Automata aims to accelerate its growth and expand its industry presence across the US, UK, and EMEA.
Automata, led by Founder and CEO Mostafa Elsayed, specializes in robotics and automation solutions for laboratories.
Their LINQ automation platform offers a range of features including software that enables scientists to design, schedule, and run workflows, proprietary hardware that forms the core of a lab's robotics ecosystem, and data availability at every stage of an experiment or workflow. The company takes an OEM agnostic approach, allowing seamless integration with various labs and equipment.
Automata's customer base is diverse and includes renowned organizations like NHS Trusts such as The Royal Marsden NHS Foundation Trust, academic institutions like The Francis Crick Institute, testing labs such as HSL, CDMOs and CROs, as well as pharma and biotech companies like AstraZeneca and bit.bio.
They've invested in Automata Technologies
Get to know these Biotech investors
| Investor | Sector | Stage | Activity | Team | Connect |
|---|---|---|---|---|---|
 Dimension | 1 investment investment | 5 contacts contacts | |||
 A.P. Moller Holding | 3 investments investments | more info | |||
 Octopus Ventures | 43 investments investments | 14 contacts contacts | |||
 Hummingbird | 3 investments investments | 7 contacts contacts | |||
 Isomer Capital | 2 investments investments | 6 contacts contacts |
Click here for a full list of 7,526+ startup investors in the UK